RACHEL GROVES: Open Payments
NPI 1114609161 · LAKE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,356 in 82 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $668 · 2025 $1,356
Food & beverage: $1,356
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $243 |
| Phathom Pharmaceuticals, Inc. | 29 | $238 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $175 |
| Aimmune Therapeutics, Inc. | 7 | $162 |
| Ardelyx, Inc. | 6 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
| Janssen Biotech, Inc. | 3 | $89 |
| PFIZER INC. | 3 | $64 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Novo Nordisk Inc | 1 | $30 |
Products named: VOQUEZNA, ZENPEP, IBSRELA, XIFAXAN, TREMFYA, ENTYVIO, LINZESS, RINVOQ.
Industry payments across FL — which companies pay providers there.
